Search research articles
Contact Us
Filters
Showing results (31-40 of 40) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 40 results.
Carcinogenesis
|
June 1, 1994
Combined effect of CYP1A1 inducibility and GSTM1 polymorphism on histological type of lung cancer
S Anttila, A Hirvonen, K Husgafvel-Pursiainen, et al.
Clinical Rheumatology
|
October 13, 2018
Correction to: Efficacy of certolizumab pegol with and without concomitant use of disease-modifying anti-rheumatic drugs over 4 years in psoriatic arthritis patients: results from the RAPID-PsA randomized controlled trial
J A Walsh, A B Gottlieb, B Hoepken, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Long-Term Maintenance of Improvements in Patient-Reported Outcomes With Certolizumab Pegol in Patients With Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis: 96-Week Results of the Rapid-Axspa Study
J Sieper, A Kivitz, A van Tubergen, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
September 25, 2016
Search for KPNA7 cargo proteins in human cells reveals MVP and ZNF414 as novel regulators of cancer cell growth
Elisa M Vuorinen, Nina K Rajala, Hanna E Rauhala, et al.
Arthritis Care & Research
|
October 4, 2016
Early Disease Activity or Clinical Response as Predictors of Long-Term Outcomes With Certolizumab Pegol in Axial Spondyloarthritis or Psoriatic Arthritis
D van der Heijde, A Deodhar, R Fleischmann, et al.
Cancer Research
|
August 1, 1995
Pulmonary expression of glutathione S-transferase M3 in lung cancer patients: association with GSTM1 polymorphism, smoking, and asbestos exposure
S Anttila, L Luostarinen, A Hirvonen, et al.
Bioscience Reports
|
December 10, 1999
Leukocyte adhesion--an integrated molecular process at the leukocyte plasma membrane
C G Gahmberg, L Valmu, A Kotovuori, et al.
International Journal of Cancer
|
May 8, 2000
Expression of CYP1A1, CYP1B1 and CYP3A, and polycyclic aromatic hydrocarbon-DNA adduct formation in bronchoalveolar macrophages of smokers and non-smokers
R Piipari, K Savela, T Nurminen, et al.
Arthritis Care & Research
|
January 28, 2016
Observed Incidence of Uveitis Following Certolizumab Pegol Treatment in Patients With Axial Spondyloarthritis
M Rudwaleit, J T Rosenbaum, R Landewé, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
December 4, 2014
Effect of certolizumab pegol over ninety-six weeks in patients with axial spondyloarthritis: results from a phase III randomized trial
J Sieper, R Landewé, M Rudwaleit, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 40) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 40 results.
Carcinogenesis
|
June 1, 1994
Combined effect of CYP1A1 inducibility and GSTM1 polymorphism on histological type of lung cancer
S Anttila, A Hirvonen, K Husgafvel-Pursiainen, et al.
Clinical Rheumatology
|
October 13, 2018
Correction to: Efficacy of certolizumab pegol with and without concomitant use of disease-modifying anti-rheumatic drugs over 4 years in psoriatic arthritis patients: results from the RAPID-PsA randomized controlled trial
J A Walsh, A B Gottlieb, B Hoepken, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Long-Term Maintenance of Improvements in Patient-Reported Outcomes With Certolizumab Pegol in Patients With Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis: 96-Week Results of the Rapid-Axspa Study
J Sieper, A Kivitz, A van Tubergen, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
September 25, 2016
Search for KPNA7 cargo proteins in human cells reveals MVP and ZNF414 as novel regulators of cancer cell growth
Elisa M Vuorinen, Nina K Rajala, Hanna E Rauhala, et al.
Arthritis Care & Research
|
October 4, 2016
Early Disease Activity or Clinical Response as Predictors of Long-Term Outcomes With Certolizumab Pegol in Axial Spondyloarthritis or Psoriatic Arthritis
D van der Heijde, A Deodhar, R Fleischmann, et al.
Cancer Research
|
August 1, 1995
Pulmonary expression of glutathione S-transferase M3 in lung cancer patients: association with GSTM1 polymorphism, smoking, and asbestos exposure
S Anttila, L Luostarinen, A Hirvonen, et al.
Bioscience Reports
|
December 10, 1999
Leukocyte adhesion--an integrated molecular process at the leukocyte plasma membrane
C G Gahmberg, L Valmu, A Kotovuori, et al.
International Journal of Cancer
|
May 8, 2000
Expression of CYP1A1, CYP1B1 and CYP3A, and polycyclic aromatic hydrocarbon-DNA adduct formation in bronchoalveolar macrophages of smokers and non-smokers
R Piipari, K Savela, T Nurminen, et al.
Arthritis Care & Research
|
January 28, 2016
Observed Incidence of Uveitis Following Certolizumab Pegol Treatment in Patients With Axial Spondyloarthritis
M Rudwaleit, J T Rosenbaum, R Landewé, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
December 4, 2014
Effect of certolizumab pegol over ninety-six weeks in patients with axial spondyloarthritis: results from a phase III randomized trial
J Sieper, R Landewé, M Rudwaleit, et al.
Page
of 4